Taken together, these data show that hypo-N-glycosylation in synucleinopathy occurs through deficits in GFPT2, and restoring its expression can rescue lysosomal function, reduce α-syn, and improve neuronal health. This evidence concerns the gene GFPT2 and synucleinopathy.